Findings

What do systematic reviews say?

10 questions · 10 findings · 4 reviews · Vascular

Sort:Best matchNewest Highest certainty Download CSV

No studies found 7 · 70%GRADE not reported 0 · 0%Very low 1 · 10%Low 1 · 10%Moderate 1 · 10%High 0 · 0%

Alpha‐blockers vs placebo

QoL · primary Raynaud's phenomenon

The review found no eligible studies for this question.

1 finding from 1 review

Vasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prostagladin/prostacyclin analogues vs placebo

QoL · primary Raynaud's phenomenon

The review found no eligible studies for this question.

1 finding from 1 review

Vasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Thromboxane synthase inhibitors vs placebo

QoL · primary Raynaud's phenomenon

The review found no eligible studies for this question.

1 finding from 1 review

Vasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Selective serotonin reuptake inhibitors vs placebo

QoL · primary Raynaud's phenomenon

The review found no eligible studies for this question.

1 finding from 1 review

Vasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Nitrate/nitrate derivatives vs placebo

QoL · primary Raynaud's phenomenon

The review found no eligible studies for this question.

1 finding from 1 review

Vasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Angiotensin‐converting enzyme inhibitors vs placebo

QoL · primary Raynaud's phenomenon

The review found no eligible studies for this question.

1 finding from 1 review

Vasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Phosphodiesterase inhibitors vs placebo

QoL · primary Raynaud's phenomenon

The review found no eligible studies for this question.

1 finding from 1 review

Vasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Pentoxifylline vs placebo

QoL · intermittent claudication

1 finding from 1 review

Pentoxifylline for intermittent claudication 2020 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 1179 participants
Moderate

Cilostazol vs placebo

Quality of life (change in points, SF‐36, WIQ) · intermittent claudication

1 finding from 1 review

Cilostazol for intermittent claudication 2021 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 1163 participants
Low

Foam sclerotherapy vs placebo

QoL · participants with varicose veinsa

1 finding from 1 review

Injection sclerotherapy for varicose veins 2021 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 299 participants
Very low